Back to 
DANSKE BANK A/S
DANSKE BANK A/S
CORT
Showing 7 of 9 quarters
Position history for DANSKE BANK A/S's holdings in CORCEPT THERAPEUTICS INC
No. Danske Bank exited its CORT (Corcept Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 1,100 shares worth $38,280. Danske Bank already held CORT in its Q1 2024 13F, the earliest on record, and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.8M
Total Shares Change
-38,916
Quarter-by-Quarter History